Relationship of urine dopamine with phosphorus homeostasis in humans: The heart and soul study

American Journal of Nephrology

Volumn 35, Issue 6, 2012, Pages 483-490

  Bansal, Nisha ^a   Hsu, Chi Yuan ^a   Whooley, Mary ^a,b,c   Berg, Anders H ^d   Ix, Joachim H ^e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Kidney; Phosphorus; Proximal tubule; Urine dopamine

Indexed keywords

DIURETIC AGENT; DOPAMINE; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS;

AGE; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; DOPAMINE URINE LEVEL; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HOMEOSTASIS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX; SMOKING; URINALYSIS;

AGED; AGED, 80 AND OVER; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DOPAMINE; FEMALE; FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; PHOSPHORUS, DIETARY; RENAL INSUFFICIENCY, CHRONIC;

EID: 84860849938     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000338483     Document Type: Article

References (28)

1. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS: Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007; 167: 879-885.
2. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005; 112: 2627-2633.
3. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF: Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 2011; 305: 1119-1127.
4. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87:E10-E17.
5. Marks J, Debnam ES, Unwin RJ: Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol Renal Physiol 2010; 299:F285-F296.
6. Suzuki H, Nakane H, Kawamura M, Yoshizawa M, Takeshita E, Saruta T: Excretion and metabolism of dopa and dopamine by isolated perfused rat kidney. Am J Physiol 1984; 247:E285-E290.
7. Debska-Slizien A, Ho P, Drangova R, Baines AD: Endogenous renal dopamine production regulates phosphate excretion. Am J Physiol 1994; 266:F858-F867.
8. Debska-Slizien A, Ho P, Drangova R, Baines AD: Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys. J Am Soc Nephrol 1994; 5: 1125-1132.
9. Berndt TJ, Khraibi AA, Thothathri V, Dousa TP, Tyce GM, Knox FG: Effect of increased dietary phosphate intake on dopamine excretion in the presence and absence of the renal nerves. Miner Electrolyte Metab 1994; 20: 158-162.
10. Weinman EJ, Biswas R, Steplock D, Wang P, Lau YS, Desir GV, Shenolikar S: Increased renal dopamine and acute renal adaptation to a high-phosphate diet. Am J Physiol Renal Physiol 2011; 300:F1123-F1129.
11. Isaac J, Berndt TJ, Chinnow SL, Tyce GM, Dousa TP, Knox FG: Dopamine enhances the phosphaturic response to parathyroid hormone in phosphate-deprived rats. J Am Soc Nephrol 1992; 2: 1423-1429.
12. Whooley MA, de Jonge P, Vittinghoff E, Otte C, Moos R, Carney RM, Ali S, Dowray S, Na B, Feldman MD, Schiller NB, Browner WS: Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008; 300: 2379-2388.
13. Ix JH, de Boer IH, Wassel CL, Criqui MH, Shlipak MG, Whooley MA: Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the heart and soul study. Circulation 2010; 121: 1295-1303.
14. Arup laboratories: Catecholamines: Fractionated, plasma and urine free. www.aruplab. com/guides /cl t /t e s t s /cl t-a151. jsp#1059229 (accessed January, 2012).
15. Otte C, Neylan TC, Pipkin SS, Browner WS, Whooley MA: Depressive symptoms and 24- hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the heart and soul study. Am J Psychiatry 2005; 162: 2139-2145.
16. Ix JH, Chonchol M, Laughlin GA, Shlipak MG, Whooley MA: Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the heart and soul study. Am J Kidney Dis 2011; 58: 737-745.
17. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H: Fibroblast growth factor 23 in oncogenic osteomalacia and xlinked hypophosphatemia. N Engl J Med 2003; 348: 1656-1663.
18. Erlandsen EJ, Randers E, Kristensen JH: Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 1999; 59: 1-8.
19. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van Lente F, Bruce RD 3rd, Zhang YL, Greene T, Levey AS: Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395-406.
20. Ix JH, Shlipak MG, Chertow GM, Whooley MA: Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the heart and soul study. Circulation 2007; 115: 173-179.
21. Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA: Fetuin- A and kidney function in persons with coronary artery disease - data from the heart and soul study. Nephrol Dial Transplant 2006; 21: 2144-2151.
22. Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S: Depression and inflammation in patients with coronary heart disease: findings from the heart and soul study. Biol Psychiatry 2007; 62: 314-320.
23. Cunningham R, Biswas R, Brazie M, Steplock D, Shenolikar S, Weinman EJ: Signaling pathways utilized by PTH and dopamine to inhibit phosphate transport in mouse renal proximal tubule cells. Am J Physiol Renal Physiol 2009; 296:F355-F361.
24. Isaac J, Berndt TJ, Thothathri V, Tyce GM, Knox FG: Catecholamines and phosphate excretion by the remnant kidney. Kidney Int 1993; 43: 1021-1026.
25. Bacic D, Capuano P, Baum M, Zhang J, Stange G, Biber J, Kaissling B, Moe OW, Wagner CA, Murer H: Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol 2005; 288:F740-F747.
26. Baines AD, Drangova R: Does dopamine use several signal pathways to inhibit Na-Pi transport in OK cells? J Am Soc Nephrol 1998; 9: 1604-1612.
27. Sampaio-Maia B, Moreira-Rodrigues M, Pestana M: Role of chronic inhibition of dopamine- metabolizing enzymes in the regulation of renal sodium and phosphate excretion in the rat remnant kidney. Nephron Physiol 2006; 103: 14-24.
28. Berndt T, Thomas LF, Craig TA, Sommer S, Li X, Bergstralh EJ, Kumar R: Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci USA 2007; 104: 11085-11090.